CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
Sylvain Lefort(Université Claude Bernard Lyon 1), Fatima Mechta‐Grigoriou(Inserm)
Cited by 82
Related Papers
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
|Nature Communications|2020|374
Oxidative stress promotes myofibroblast differentiation and tumour spreading
|EMBO Molecular Medicine|2010|333
PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers
|Cell Metabolism|2018|297
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
|Nature Communications|2018|276
Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients
|EMBO Molecular Medicine|2016|179